Advaxis Inc. (NASDAQ: ADXS) stock plunged to a record low of $1.54 on Tuesday as the late-stage biotech company has returned the prepayments it received…
Posts tagged as Advaxis
Advaxis (NASDAQ: ADXS) report that Q2 revenue decreased to $1.2 million from $1.7 million in the prior year quarter. The 32% decline in revenue was…
Late-stage biotech firm Advaxis, Inc. (NASDAQ: ADXS) is scheduled to report second-quarter financial results on June 10, Monday, after the closing bell. Analysts expect the…